AAAAAA

   
Results: 1-24 |
Results: 24
AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN ITALY
Authors: MESSINA C CESARO S RONDELLI R ROSSETTI F LOCATELLI F PESSION A MINIERO R DINI G UDERZO C DALLORSO S MELONI G VIGNETTI M ANDOLINA M PORTA F AMICI A FAVRE C BASSO G SOTTI G VAROTTO S DESTRO R GAZZOLA MV PILLON M PETRIS MG RABUSIN M SCARZELLO G ZANESCO L
Citation: C. Messina et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN ITALY, Bone marrow transplantation, 21(10), 1998, pp. 1015-1021
OUTCOME OF ACUTE MYELOID-LEUKEMIA (AML) RELAPSING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN FIRST REMISSION
Authors: VIGNETTI M IACOPINO P TRASARTI S MESSINA G BARBUI T CARELLA AM ALESSANDRINO PP BENEDETTI F FALDA M SAJEVA MT CARLOSTELLA C LAMBERTENGHI G SICA S VISANI G MELONI G
Citation: M. Vignetti et al., OUTCOME OF ACUTE MYELOID-LEUKEMIA (AML) RELAPSING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN FIRST REMISSION, Bone marrow transplantation, 21, 1998, pp. 13-13
INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA
Authors: MELONI G VIGNETTI M POGLIANI E INVERNIZZI R ALLIONE B MIRTO S SICA S LEONI F SELLERI C MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA, The cancer journal from Scientific American, 3, 1997, pp. 43-47
USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS
Authors: CARLOSTELLA C REGAZZI E ANDRIZZI C SAVOLDO B GARAU D MONTEFUSCO E VIGNETTI M MANDELLI F RIZZOLI V MELONI G
Citation: C. Carlostella et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS, Haematologica, 82(3), 1997, pp. 291-296
EFFECT OF CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA ON HEMATOPOIETIC AND FIBROBLAST MARROW PROGENITORS
Authors: CARLOSTELLA C TABILIO A REGAZZI E GARAU D LATAGLIATA R TRASARTI S ANDRIZZI C VIGNETTI M MELONI G
Citation: C. Carlostella et al., EFFECT OF CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA ON HEMATOPOIETIC AND FIBROBLAST MARROW PROGENITORS, Bone marrow transplantation, 20(6), 1997, pp. 465-471
AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE PROMYELOCYTIC LEUKEMIA IN 2ND REMISSION - PROGNOSTIC RELEVANCE OF PRETRANSPLANT MINIMAL RESIDUAL DISEASE ASSESSMENT BY REVERSE-TRANSCRIPTION POLYMERASE CHAIN-REACTION OF THE PML RAR-ALPHA FUSION GENE/
Authors: MELONI G DIVERIO D VIGNETTI M AVVISATI G CAPRIA S PETTI MC MANDELLI F LOCOCO F
Citation: G. Meloni et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE PROMYELOCYTIC LEUKEMIA IN 2ND REMISSION - PROGNOSTIC RELEVANCE OF PRETRANSPLANT MINIMAL RESIDUAL DISEASE ASSESSMENT BY REVERSE-TRANSCRIPTION POLYMERASE CHAIN-REACTION OF THE PML RAR-ALPHA FUSION GENE/, Blood, 90(3), 1997, pp. 1321-1325
UNMANIPULATED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN REMISSION AFTER FLUDARABINE THERAPY
Authors: MELONI G MAURO F DEFABRITIS P GUGLIELMI C PESCARMONA E PROIA A VIGNETTI M FOA R MANDELLI F
Citation: G. Meloni et al., UNMANIPULATED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS IN REMISSION AFTER FLUDARABINE THERAPY, Blood, 90(10), 1997, pp. 4241-4241
BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA IN LONG-LASTING SYSTEMICLUPUS-ERYTHEMATOSUS - REGRESSION OF BOTH DISEASES AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: MELONI G CAPRIA S VIGNETTI M MANDELLI F MODENA V
Citation: G. Meloni et al., BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA IN LONG-LASTING SYSTEMICLUPUS-ERYTHEMATOSUS - REGRESSION OF BOTH DISEASES AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 89(12), 1997, pp. 4659-4659
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN 44 PATIENTS WITH AGGRESSIVENON-HODGKINS-LYMPHOMA AT UNIVERSITY-LA-SAPIENZA OF ROME
Authors: CAPRIA S VIGNETTI M PROIA A CARUSO R COPPOLA L ORSINI E MELONI G
Citation: S. Capria et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN 44 PATIENTS WITH AGGRESSIVENON-HODGKINS-LYMPHOMA AT UNIVERSITY-LA-SAPIENZA OF ROME, Leukemia & lymphoma, 23(1-2), 1996, pp. 147-151
INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE - UPDATED EXPERIENCE WITH 20 CASES
Authors: MELONI G VIGNETTI M ANDRIZZI C CAPRIA S FOA R MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE - UPDATED EXPERIENCE WITH 20 CASES, Leukemia & lymphoma, 21(5-6), 1996, pp. 429-435
PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE
Authors: VIGNETTI M ORSINI E PETTI MC MOLETI ML ANDRIZZI C PINTO RM AMADORI S MELONI G
Citation: M. Vignetti et al., PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE, Annals of oncology, 7(9), 1996, pp. 933-938
HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY
Authors: MARTELLI M VIGNETTI M ZINZANI PL GHERLINZONI F MELONI G FIACCHINI M DESANCTIS V PAPA G MARTELLI MF CALABRESI F TURA S MANDELLI F
Citation: M. Martelli et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY, Journal of clinical oncology, 14(2), 1996, pp. 534-542
LACK OF EFFICACY OF A DOUBLE AUTOGRAFT PROGRAM TO PROLONG SURVIVAL OFCHRONIC MYELOGENOUS LEUKEMIA PATIENTS IN ELASTIC TRANSFORMATION
Authors: CAPRIA S VIGNETTI M MONTEFUSCO E CARDILLO AMF SIMONE F MELONI G
Citation: S. Capria et al., LACK OF EFFICACY OF A DOUBLE AUTOGRAFT PROGRAM TO PROLONG SURVIVAL OFCHRONIC MYELOGENOUS LEUKEMIA PATIENTS IN ELASTIC TRANSFORMATION, Haematologica, 81(4), 1996, pp. 349-351
BAVC REGIMEN AND AUTOGRAFT FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND COMPLETE REMISSION
Authors: MELONI G VIGNETTI M AVVISATI G CAPRIA S MICOZZI A GIONA F MANDELLI F
Citation: G. Meloni et al., BAVC REGIMEN AND AUTOGRAFT FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND COMPLETE REMISSION, Bone marrow transplantation, 18(4), 1996, pp. 693-698
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA - REPORT FROM THE ITALIAN NATIONAL PEDIATRIC REGISTRY (AIEOP-BMT)
Authors: VIGNETTI M RONDELLI R LOCATELLI F LANINO E MINIERO R ROSSETTI F MELONI G
Citation: M. Vignetti et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA - REPORT FROM THE ITALIAN NATIONAL PEDIATRIC REGISTRY (AIEOP-BMT), Bone marrow transplantation, 18, 1996, pp. 59-62
AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA TREATED WITH LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: MELONI G ANDRIZZI C VIGNETTI M GIRELLI G MANDELLI F
Citation: G. Meloni et al., AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA TREATED WITH LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 86(2), 1995, pp. 837-838
MYELODYSPLASTIC SYNDROMES IN CHILDHOOD - DESCRIPTION OF 7 CASES
Authors: VITALE A TESTI AM MOLETI ML VIGNETTI M ARCESE W FENU S CEDRONE M DEFELICE L AMADORI S MANDELLI F
Citation: A. Vitale et al., MYELODYSPLASTIC SYNDROMES IN CHILDHOOD - DESCRIPTION OF 7 CASES, Annals of hematology, 68(5), 1994, pp. 241-245
AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN REMISSION - FIRST CHOICE FOR ISOLATED EXTRAMEDULLARY RELAPSE
Authors: COLLESELLI P ROSSETTI F MESSINA C RONDELLI R DINI G MELONI G MINIERO R ANDOLINA M LOCATELLI F AMICI A FAVRE C UDERZO C VIGNETTI M DALLORSO S PESSION A
Citation: P. Colleselli et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN REMISSION - FIRST CHOICE FOR ISOLATED EXTRAMEDULLARY RELAPSE, Bone marrow transplantation, 14(5), 1994, pp. 821-825
INTERLEUKIN-2 MAY INDUCE PROLONGED REMISSIONS IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA
Authors: MELONI G FOA R VIGNETTI M GUARINI A FENU S TOSTI S TOS AG MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 MAY INDUCE PROLONGED REMISSIONS IN ADVANCED ACUTE MYELOGENOUS LEUKEMIA, Blood, 84(7), 1994, pp. 2158-2163
AUTOLOGOUS BMT IN 199 AML PATIENTS IN CR - 10-YEAR EXPERIENCE AT THE HEMATOLOGY OF THE UNIVERSITY-LA-SAPIENZA OF ROME, ITALY
Authors: MELONI G VIGNETTI M AVVISATI G ANDRIZZI C CAPRIA S ORSINI E SIMONE F TODISCO E VEGNA ML MANDELLI F
Citation: G. Meloni et al., AUTOLOGOUS BMT IN 199 AML PATIENTS IN CR - 10-YEAR EXPERIENCE AT THE HEMATOLOGY OF THE UNIVERSITY-LA-SAPIENZA OF ROME, ITALY, Blood, 84(10), 1994, pp. 10000202-10000202
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VS DHAP IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) PARTIALLY RESPONDING TO 1ST LINE CHEMOTHERAPY
Authors: GHERLINZONI F MARTELLI M MAZZA P ZINZANI PL PILERI S BOCCHIA M MELONI G VIGNETTI M GUGLIELMI C AMADORI S ANTIMI M BURGIO VL MARTELLI MF FALINI B LIBERATI AM BENDANDI M MIGGIANO MC CALABRESI F DAMMACCO F LUCARELLI G MORETTI L MANDELLI F TURA S
Citation: F. Gherlinzoni et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VS DHAP IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) PARTIALLY RESPONDING TO 1ST LINE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000234-10000234
INTERLEUKIN-2 TREATMENT IN ACUTE MYELOGENOUS LEUKEMIA
Authors: MANDELLI F VIGNETTI M TOSTI S ANDRIZZI C FOA R MELONI G
Citation: F. Mandelli et al., INTERLEUKIN-2 TREATMENT IN ACUTE MYELOGENOUS LEUKEMIA, Stem cells, 11(4), 1993, pp. 263-268
HEMATOLOGICAL MONITORING OF ACUTE LYMPHOBLASTIC-LEUKEMIA BY AUTOMATEDFLOW CYTOCHEMISTRY (BAYER TECHNICON H-ASTERISK-1)
Authors: IALONGO P LUBRANO MC FENU S VIGNETTI M MANDELLI F
Citation: P. Ialongo et al., HEMATOLOGICAL MONITORING OF ACUTE LYMPHOBLASTIC-LEUKEMIA BY AUTOMATEDFLOW CYTOCHEMISTRY (BAYER TECHNICON H-ASTERISK-1), Haematologica, 78(2), 1993, pp. 89-94
INTERLEUKIN-2 TREATMENT IN ACUTE MYELOBLASTIC-LEUKEMIA IN DIFFERENT PHASES OF DISEASE
Authors: MELONI G VIGNETTI M ANDRIZZI C CAPRIA S FOWST C BOTTONI A FOA R MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 TREATMENT IN ACUTE MYELOBLASTIC-LEUKEMIA IN DIFFERENT PHASES OF DISEASE, Blood, 82(10), 1993, pp. 10000543-10000543
Risultati: 1-24 |